CANTEL MEDICAL

 CMDのチャート


 CMDの企業情報

symbol CMD
会社名 Cantel Medical Corp (CANTEL MEDICAL)
分野(sector)   
産業(industry)   
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 カンテル・メディカル(Cantel Medical Corp.)はヘルスケア市場向けに感染予防・管理の製品とサービスを提供する会社である。同社は、内視鏡検査、 浄水・水処理、ヘルスケアディスポーザブル及び透析の4つの事業セグメントを通じて事業を行う。内視鏡セグメントにおいて、同社は医療機器再処理システム、消毒剤、洗剤及びその他の消耗品を提供する。浄水・水処理セグメントにおいて、同社は、浄水の装置・サービス、濾過・分離製品、消毒剤及び滅菌・除染の製品・サービスを提供する。ヘルスケアディスポーザブルセグメントにおいて、同社はシングルユースの使用、感染予防及び管理ヘルスケア製品を提供する。透析セグメントにおいて、同社は医療機器の再処理システム、滅菌剤・消毒剤、透析液濃縮物及びその他の腎臓透析用品を提供する。また、同社は、中空糸膜技術を利用するフィルターも提供する。  キャンテル・メディカルは、ヘルスケア市場の米国メ―カ―。感染予防とコントロ―ル製品やサ―ビスを展開。医療機器の再処理システム、内視鏡を消毒するために使用される消毒剤、洗剤やその他の消耗品を提供する。また、水浄化装置とサ―ビス、感染予防と規制ヘルスケア製品、腎臓透析用の透析濃縮物やその他の製品、梱包用品や保温製品などを提供。  Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. It operates through the following business segments: Medical, Life Sciences, Dental and Dialysis. The Medical segment designs, develops, manufactures, sells and installs a comprehensive offering of products and services comprising a complete circle of infection prevention solutions. The Life Sciences segment designs, develops, manufactures, sells and installs water purification systems for medical, pharmaceutical and other bacteria controlled applications. The Dental segment designs, manufactures, sells, supplies and distributes a broad selection of infection prevention healthcare products, the majority of which are single-use products used by dental practitioners. The Dialysis segment designs, develops, manufactures, sells and services reprocessing systems and sterilants for dialyzers, as well as dialysate concentrates and supplies utilized for renal dialysis. Cantel Medical was founded on August 16, 1963 and is headquartered in Little Falls, NJ.
本社所在地 150 Clove Road Little Falls NJ 07424 USA
代表者氏名 Charles M Diker
代表者役職名 Chairman of the Board
電話番号 +1 973-890-7220
設立年月日 1952年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 2693人
url www.cantelmedical.com
nasdaq_url
adr_tso
EBITDA (百万ドル) 162.51900
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 2836.21400
売上高 (百万ドル) 896.24900
企業価値(EV) (百万ドル) 3002.76000
当期純利益 (百万ドル) 74.16000
決算概要 BRIEF: For the six months ended 31 January 2019 Cantel Medical Corp. revenues increased 6% to $450.1M. Net income applicable to common stockholders excluding extraordinary items decreased 17% to $38.9M. Revenues reflect Medical segment increase of 12% to $256.1M Dialysis segment increase of 2% to $16.2M Europe/Africa/Middle East segment increase from $28.1M to $66.3M Asia/Pacific-Oceania segment increase from $13.6M to $31.3M.
symbol CMD
会社名 Cantel Medical Corp (キャンテル・メディカル)
分野(sector)   
産業(industry)   
業種    医療関連(Health Care)
概要 カンテル・メディカル(Cantel Medical Corp.)はヘルスケア市場向けに感染予防・管理の製品とサービスを提供する会社である。同社は、内視鏡検査、 浄水・水処理、ヘルスケアディスポーザブル及び透析の4つの事業セグメントを通じて事業を行う。内視鏡セグメントにおいて、同社は医療機器再処理システム、消毒剤、洗剤及びその他の消耗品を提供する。浄水・水処理セグメントにおいて、同社は、浄水の装置・サービス、濾過・分離製品、消毒剤及び滅菌・除染の製品・サービスを提供する。ヘルスケアディスポーザブルセグメントにおいて、同社はシングルユースの使用、感染予防及び管理ヘルスケア製品を提供する。透析セグメントにおいて、同社は医療機器の再処理システム、滅菌剤・消毒剤、透析液濃縮物及びその他の腎臓透析用品を提供する。また、同社は、中空糸膜技術を利用するフィルターも提供する。  キャンテル・メディカルは、ヘルスケア市場の米国メ―カ―。感染予防とコントロ―ル製品やサ―ビスを展開。医療機器の再処理システム、内視鏡を消毒するために使用される消毒剤、洗剤やその他の消耗品を提供する。また、水浄化装置とサ―ビス、感染予防と規制ヘルスケア製品、腎臓透析用の透析濃縮物やその他の製品、梱包用品や保温製品などを提供。  Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. It operates through the following business segments: Medical, Life Sciences, Dental and Dialysis. The Medical segment designs, develops, manufactures, sells and installs a comprehensive offering of products and services comprising a complete circle of infection prevention solutions. The Life Sciences segment designs, develops, manufactures, sells and installs water purification systems for medical, pharmaceutical and other bacteria controlled applications. The Dental segment designs, manufactures, sells, supplies and distributes a broad selection of infection prevention healthcare products, the majority of which are single-use products used by dental practitioners. The Dialysis segment designs, develops, manufactures, sells and services reprocessing systems and sterilants for dialyzers, as well as dialysate concentrates and supplies utilized for renal dialysis. Cantel Medical was founded on August 16, 1963 and is headquartered in Little Falls, NJ.
本社所在地 150 Clove Road Little Falls NJ 07424 USA
代表者氏名
代表者役職名
電話番号
設立年月日 1952年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 2000人
url www.cantelmedical.com
nasdaq_url
adr_tso
EBITDA
終値(lastsale)
時価総額(marketcap)
時価総額
売上高
企業価値(EV)
当期純利益
決算概要

 CMDのテクニカル分析


 CMDのニュース

   Offsite Sterilization Services Market 2020 Size, Share, Global Trends, Comprehensive Research Study, Opportunities, Leading Players are Cantel Medical, Cretex Companies, Noxilizer, Sterilmed, Stryker, 3M, Belimed  2020/10/14 12:02:16 OpenPR
The winning Offsite Sterilization Services Market report makes available the current and forthcoming technical and financial details of the industry. Few of the chief insights of this business report include; distinct analysis of the market drivers & restraints, major market
   Latest Trends in Sterilization Validation Service Market 2020, Covers Updates on Share, Size, Global Industry Growth Factors- STERIS, Sterigenics International, Cantel Medical  2020/10/05 17:29:57 OpenPR
This comprehensive report gives significant insights into the Sterilization Validation Service market at global, regional and individual company levels. Various factors like market size, market growth rate, submarkets, the compounded annual growth rate (CAGR) and the production and consumption capacities
   Cantel Hires Michael Drexel to SVP and Chief Technology Officer  2020/10/01 11:00:00 PR Newswire
LITTLE FALLS, N.J., Oct. 1, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP (NYSE:CMD) announced today that Michael Drexel has been hired as Senior Vice President and Chief Technology Officer reporting to George Fotiades, Chief Executive Officer. Michael is based in Plymouth, Minnesota. Mr….
   Cantel Medical Corp. (CMD) CEO George Fotiades on Q4 2020 Results - Earnings Call Transcript  2020/09/17 17:25:02 Seeking Alpha
Cantel Medical Corp. (NYSE:CMD) Q4 2020 Earnings Conference Call September 17, 2020, 08:30 AM ET Company Participants Matt Micowski - VP, IR and Financial Planning and Analysis George Fotiades - President and CEO Shaun Blakeman - SVP and CFO Peter Clifford - EVP and COO Seth Yellin - EVP, Strategy and Corporate Development Conference Call Participants Larry Keusch - Raymond James Matthew Mishan - KeyBanc Capital Markets Mitra Ramgopal - Sidoti & Company Mike Matson - Needham & Company Presentation Operator Hello, everyone, and thank you for joining us today, for this Cantel Medical Fourth Quarter 2020 Earnings Call.
   Cantel Medical Reports Financial Results for its Fourth Quarter Fiscal Year 2020  2020/09/17 11:00:00 PR Newswire
LITTLE FALLS, N.J., Sept. 17, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its fourth quarter ended July 31, 2020. Fourth quarter 2020 net sales were $233.4M, down 2.5% compared to the prior year. Excluding the impact of foreign currency, net…
   Cantel Hires Michael Drexel to SVP and Chief Technology Officer  2020/10/01 11:00:00 PR Newswire
LITTLE FALLS, N.J., Oct. 1, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP (NYSE:CMD) announced today that Michael Drexel has been hired as Senior Vice President and Chief Technology Officer reporting to George Fotiades, Chief Executive Officer. Michael is based in Plymouth, Minnesota. Mr….
   Cantel Medical Corp. (CMD) CEO George Fotiades on Q4 2020 Results - Earnings Call Transcript  2020/09/17 17:25:02 Seeking Alpha
Cantel Medical Corp. (NYSE:CMD) Q4 2020 Earnings Conference Call September 17, 2020, 08:30 AM ET Company Participants Matt Micowski - VP, IR and Financial Planning and Analysis George Fotiades - President and CEO Shaun Blakeman - SVP and CFO Peter Clifford - EVP and COO Seth Yellin - EVP, Strategy and Corporate Development Conference Call Participants Larry Keusch - Raymond James Matthew Mishan - KeyBanc Capital Markets Mitra Ramgopal - Sidoti & Company Mike Matson - Needham & Company Presentation Operator Hello, everyone, and thank you for joining us today, for this Cantel Medical Fourth Quarter 2020 Earnings Call.
   Cantel Medical Reports Financial Results for its Fourth Quarter Fiscal Year 2020  2020/09/17 11:00:00 PR Newswire
LITTLE FALLS, N.J., Sept. 17, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its fourth quarter ended July 31, 2020. Fourth quarter 2020 net sales were $233.4M, down 2.5% compared to the prior year. Excluding the impact of foreign currency, net…
   Earnings Scheduled For September 17, 2020  2020/09/17 08:04:27 Benzinga
Companies Reporting Before The Bell • Apogee Enterprises (NASDAQ: APOG ) is projected to report quarterly earnings at $0.30 per share on revenue of $314.73 million. • Cantel Medical (NYSE: CMD ) is expected to report … Full story available on Benzinga.com
   Cantel Medical FQ4 2020 Earnings Preview (NYSE:CMD)  2020/09/16 17:09:45 Seeking Alpha
Cantel Medical (NYSE:CMD) is scheduled to announce FQ4 earnings results on Thursday, September 17th, before market open. The consensus EPS Estimate is -$0.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 CANTEL MEDICAL CMD )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)